U.S. Healthcare Solutions was Cencora’s largest segment in fiscal 2025, bringing in $290.98B of $321.33B (91%).
| Segment | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| U.S. Healthcare Solutions | $212.10B | $234.76B | $265.34B | $290.98B | |||||||||||
| Pharmaceutical Distribution Services | — | — | — | — | |||||||||||
| Pharmaceutical Distribution | — | — | — | — | |||||||||||
| International Healthcare Solutions | $26.49B | $27.42B | $28.63B | $30.37B | |||||||||||
| Other | — | — | — | — | |||||||||||
| Other Segments | — | — | — | — | |||||||||||
| Mwi Animal Health | — | — | — | — | |||||||||||
| Global Commercialization Services | — | — | — | — | |||||||||||
| Intersegment Eliminations | -$4.87M | -$4.49M | -$8.37M | -$15.53M | |||||||||||
| Intersegment Elimination | — | — | — | — | |||||||||||
| Total | $238.59B | $262.17B | $293.96B | $321.33B |
Cencora brought in $321.33B from its three segments in fiscal 2025, the year ended September 30, 2025. That was up 9.3% from $293.96B in fiscal 2024. U.S. Healthcare Solutions was the largest at $290.98B (90.6%), ahead of International Healthcare Solutions at $30.37B (9.5%).
Compared with fiscal 2024, U.S. Healthcare Solutions grew 9.7% to $290.98B and International Healthcare Solutions grew 6.1% to $30.37B. From fiscal 2022 to 2025, combined revenue from these segments grew from $238.59B to $321.33B, a compound annual growth rate of 10.4%. U.S. Healthcare Solutions' share of the total rose from 88.9% to 90.6%.
The total is net of Intersegment Eliminations, which took $15.53M off revenue in fiscal 2025.
Human Health was Cencora’s largest segment in fiscal 2025, bringing in $285.29B of $321.33B (89%).
| Subsegments | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Human Health | $207.28B | $229.72B | $259.97B | $285.29B | |
| Alliance Healthcare | $21.89B | $22.35B | $23.06B | $24.39B | |
| Animal Health | $4.82B | $5.04B | $5.37B | $5.69B | |
| Other Healthcare Solutions | $4.60B | $5.07B | $5.57B | $5.97B | |
| Intersegment Eliminations | -$4.87M | -$4.49M | -$8.37M | -$15.53M | |
| Total | $238.59B | $262.17B | $293.96B | $321.33B |
Cencora brought in $321.33B from its five segments in fiscal 2025, the year ended September 30, 2025. That was up 9.3% from $293.96B in fiscal 2024. Human Health was the largest at $285.29B (88.8%), ahead of Alliance Healthcare at $24.39B (7.6%) and Other Healthcare Solutions at $5.97B (1.9%). The remaining segment, Animal Health, brought in $5.69B.
Compared with fiscal 2024, Human Health grew 9.7% to $285.29B and Alliance Healthcare grew 5.8% to $24.39B. From fiscal 2022 to 2025, combined revenue from these segments grew from $238.59B to $321.33B, a compound annual growth rate of 10.4%. Human Health's share of the total rose from 86.9% to 88.8%.
The total is net of Intersegment Eliminations, which took $15.53M off revenue in fiscal 2025.
Guarantor Subs was Cencora’s largest revenue line in fiscal 2009, bringing in $70.28B of $71.76B (98%).
| Legal Entity | FY 2008 | FY 2009 |
|---|---|---|
| Guarantor Subs | $68.38B | $70.28B |
| Non Guarantor Subs | $1.92B | $1.59B |
| Elimination Category | -$111.24M | -$114.07M |
| Total | $70.19B | $71.76B |
Cencora brought in $71.76B from its three revenue lines in fiscal 2009, the year ended September 30, 2009. That was up 2.2% from $70.19B in fiscal 2008. Guarantor Subs was the largest at $70.28B (97.9%), ahead of Non Guarantor Subs at $1.59B (2.2%).
Compared with fiscal 2008, Guarantor Subs grew 2.8% to $70.28B, while Non Guarantor Subs fell 17.0% to $1.59B.
The total is net of Elimination Category, which took $114.07M off revenue in fiscal 2009.
Cencora (COR) reports its revenue by segment, by subsegments and by legal entity. In fiscal 2025, U.S. Healthcare Solutions was its largest segment, bringing in $290.98B (90.6% of the total), followed by International Healthcare Solutions at $30.37B (9.5%).
U.S. Healthcare Solutions was Cencora's largest segment in fiscal 2025, bringing in $290.98B, or 90.6% of the $321.33B total across its three segments.
Guarantor Subs was Cencora's largest revenue line in fiscal 2009, bringing in $70.28B, or 97.9% of the $71.76B total across its three revenue lines.
U.S. Healthcare Solutions grew faster than International Healthcare Solutions in fiscal 2025, up 9.7% from $265.34B to $290.98B. International Healthcare Solutions grew 6.1% to $30.37B.
Every figure comes from Cencora's annual financial filings, as reported. Each line keeps the name Cencora gives it, and years follow its fiscal calendar.
Cencora's revenue by segment goes back to fiscal 2010, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.